首页> 外文OA文献 >Application Of Magnetic Resonance Imaging To Understanding The Pathogenesis Of The X-Linked Leukodystrophy Pelizaeus-Merzbacher Disease
【2h】

Application Of Magnetic Resonance Imaging To Understanding The Pathogenesis Of The X-Linked Leukodystrophy Pelizaeus-Merzbacher Disease

机译:应用磁共振成像了解X连锁的脑白质营养病 - pelzaeus-merzbacher病的发病机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myelin is a multilamellar membrane structure surrounding axons in both the CNS and PNS that facilitates nerve conduction. In the CNS, myelin is synthesized by oligodendrocytes, while in the PNS, myelin is synthesized by Schwann cells. In the CNS, Proteolipid protein 1 (PLP1), an integral membrane protein, is the major protein component of myelin, constituting ~50% of myelin protein. Mutations of the PLP1 gene in man cause a spectrum of neurological disease, ranging from the severe Pelizaeus-Merzbacher disease (PMD), that typically begins during infancy with nystagmus, seizures and hypotonia and evolves into spastic quadriparesis, cognitive impairment and ataxia, to ¡¥pure¡¦ spastic paraparesis, that is characterized exclusively by leg spasticity and weakness. The predominant pathological abnormality in PMD consists of thinning to almost complete absence of myelin in the CNS. Gow and colleagues have proposed that the severity of mutations that alter the structure of PLP1 (typically missense mutations) correlates with the degree to which they cause protein misfolding, activate the unfolded protein response, and cause oligodendrocyte apoptosis (Gow and Sharma, Neuromolecular Med 4:73, 2003). Implicit in this mechanism is that the degree of myelination should inversely correlate with the degree to which oligodendrocyte apoptosis is activated. We speculated that the early PMD phenotype predominantly is dictated by the effect on oligodendrocyte viability. In contrast, we have found that complete absence of PLP1 in both mice and humans is characterized by well-formed myelin, but late length-dependent pattern of axonal degeneration (Garbern et al. Brain 125:551, 2002). We speculate that progression of disease correlates with the rate of axonal damage. The goal of this study was to investigate whether non-invasive MR techniques to assess extent of myelination and degree of axonal disruption correlated with measures of clinical capacity. Furthermore we wanted to differentiate between axonal and myelin pathology using diffusion tensor imaging as a reliable imaging modality to assess the effects of PLP1 mutations on water diffusion in central nervous system (CNS) white matter. The most dramatic difference between PMD patients and age-matched controls was increased £ffÎ, most marked in the corpus callosum. Moreover, this was most prominent in patients with PLP1 null mutations. Increased radial diffusion has been reported in dysmyelinating rodents, including the myelin synthesis deficient rat (md) that has a severe Plp1 missense mutation. Interestingly, £f// was also increased in the severely affected PMD patients, whereas in severely dysmyelinated rodents, the £ffÎ is reported to be normal to decreased. £f// in patients with PLP1 null mutations was relatively unaffected relative to controls. Since the degree of myelination is relatively preserved in PLP1 null myelin, the increased radial diffusion is not the result of thinner myelin sheaths. Therefore the increased radial diffusion is more likely due to increased myelin water, due to decreased compaction, and which may be in part due to the existence of a ¡§radial component¡¨ to myelin, described in Plp1 null mice, created by aqueous channels that span the myelin sheath. Additional factors, such as astrocytosis, may also contribute to the increased radial diffusion.Genetic abnormalities effecting the PLP1 gene has been shown to cause axonal injury and significant early-onset dysmyelination and late-onset demyelination. The exact mutational mechanism remains to be described, although substantial progress had been made to make reasonable assessments that may provide a better understanding towards the disease pathogenesis. In the study involving autopsy tissue from genetically characterized patients has provided valuable information that describes the changes in the structural architecture of the tissue over time. These pathologic changes corroborate with the findings from the diffusion imaging making these two methods extremely reliable for describing the pathologic state as each patient experience a slightly different pathogenic course that is dependent on the exact PLP1 mutation.
机译:髓磷脂是围绕CNS和PNS中轴突的多层膜结构,有助于神经传导。在中枢神经系统中,髓鞘由少突胶质细胞合成,而在PNS中,髓鞘由雪旺氏细胞合成。在中枢神经系统中,蛋白脂质蛋白1(PLP1)是必不可少的膜蛋白,是髓磷脂的主要蛋白成分,占髓磷脂蛋白的50%。人中PLP1基因的突变会引起一系列神经系统疾病,从严重的Pelizaeus-Merzbacher疾病(PMD)开始,通常在婴儿期出现眼球震颤,癫痫发作和肌张力低下,然后演变为痉挛性四肢瘫痪,认知障碍和共济失调,再到¡纯净的痉挛性轻瘫,仅表现为腿部痉挛和无力。 PMD中主要的病理异常包括中枢神经系统变薄至髓鞘几乎完全消失。 Gow及其同事提出,改变PLP1结构的突变的严重性(通常是错义突变)与它们引起蛋白质错误折叠,激活未折叠的蛋白质反应并引起少突胶质细胞凋亡的程度有关(Gow和Sharma,Neuromolecular Med 4 :73,2003)。这种机制的暗示是髓鞘形成的程度应与少突胶质细胞凋亡被激活的程度成反比。我们推测,早期PMD表型主要受少突胶质细胞生存力的影响所决定。相反,我们发现在小鼠和人类中完全不存在PLP1的特征在于形成良好的髓磷脂,但是轴突变性的晚期长度依赖性模式(Garbern等人Brain 125:551,2002)。我们推测疾病的进展与轴突损伤的速度有关。这项研究的目的是调查评估髓鞘程度和轴突破坏程度的非侵入性MR技术是否与临床能力相关。此外,我们希望使用弥散张量成像作为可靠的成像方式来评估轴突和髓鞘病理,以评估PLP1突变对中枢神经系统(CNS)白质中水扩散的影响。 PMD患者与年龄匹配的对照之间最显着的差异是增加ffffβ,最显着的是call体。此外,这在具有PLP1空突变的患者中最为明显。据报道,在运动异常的啮齿动物中,包括在严重的Plp1错义突变的髓磷脂合成缺陷大鼠(md)中,径向扩散增加。有趣的是,在受严重影响的PMD患者中,£f //也增加了,而在严重髓鞘异常的啮齿类动物中,£ffα据报道是正常的,下降了。相对于对照组,PLP1无效突变患者中的£f //相对不受影响。由于在PLP1缺失髓磷脂中髓鞘化程度相对保留,因此径向扩散增加不是髓鞘较薄的结果。因此,径向扩散的增加​​更可能归因于髓磷脂水的增加,压实度的降低,这可能部分是由于存在于水通道形成的Plp1 null小鼠中,髓磷脂存在“径向成分”跨越髓鞘。星形细胞增多症等其他因素也可能导致径向扩散增加。已证明影响PLP1基因的遗传异常会导致轴突损伤以及严重的早发性脱髓鞘和迟发性脱髓鞘。尽管已经做出了合理的评估,可以为疾病的发病机理提供更好的理解,但是已经取得了实质性的进展,确切的突变机制还有待描述。在涉及来自具有遗传特征的患者的尸体解剖的研究中,提供了有价值的信息,这些信息描述了组织的结构结构随时间的变化。这些病理变化与弥散成像的结果相符,这使得这两种方法对于描述病理状态极为可靠,因为每个患者经历的病程略有不同,这取决于确切的PLP1突变。

著录项

  • 作者

    Laukka Jeremy Jerome;

  • 作者单位
  • 年度 2010
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号